
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis
Siming Qu, Jin Li, Hanfei Huang, et al.
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 51
Siming Qu, Jin Li, Hanfei Huang, et al.
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 51
Showing 26-50 of 51 citing articles:
Synergism in actions of HBV with aflatoxin in cancer development
Joshua Jin, Valentina L. Kouznetsova, Santosh Kesari, et al.
Toxicology (2023) Vol. 499, pp. 153652-153652
Closed Access | Times Cited: 9
Joshua Jin, Valentina L. Kouznetsova, Santosh Kesari, et al.
Toxicology (2023) Vol. 499, pp. 153652-153652
Closed Access | Times Cited: 9
Hepatitis B virus X protein and TGF-β: partners in the carcinogenic journey of hepatocellular carcinoma
Wei Yan, Dean Rao, Feimu Fan, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Wei Yan, Dean Rao, Feimu Fan, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
RNA epigenetic modifications in digestive tract cancers: Friends or foes
Zekai Nian, Ming Deng, Lele Ye, et al.
Pharmacological Research (2024) Vol. 206, pp. 107280-107280
Open Access | Times Cited: 3
Zekai Nian, Ming Deng, Lele Ye, et al.
Pharmacological Research (2024) Vol. 206, pp. 107280-107280
Open Access | Times Cited: 3
The Emerging Role of N6-Methyladenosine RNA Methylation as Regulators in Cancer Therapy and Drug Resistance
Zhaolin Chen, Ying Hu, Le Jin, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 14
Zhaolin Chen, Ying Hu, Le Jin, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 14
METTL16 regulates m6A methylation on chronic hepatitis B associated gene HLA-DPB1 involved in liver fibrosis
Haibing Gao, Xiangmei Wang, Huaxi Ma, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 13
Haibing Gao, Xiangmei Wang, Huaxi Ma, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 13
Emerging roles of biological m6A proteins in regulating virus infection: A review
Yuran Chen, Wenjing Wang, Wuchao Zhang, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 126934-126934
Closed Access | Times Cited: 8
Yuran Chen, Wenjing Wang, Wuchao Zhang, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 126934-126934
Closed Access | Times Cited: 8
Non-coding RNA methylation modifications in hepatocellular carcinoma: interactions and potential implications
Qingmiao Shi, Qingfei Chu, Yifan Zeng, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 8
Qingmiao Shi, Qingfei Chu, Yifan Zeng, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 8
Circ_0005615 enhances multiple myeloma progression through interaction with EIF4A3 to regulate MAP3K4 m6A modification mediated by ALKBH5
Kai Zhu, Feng-Quan Gou, Ziwen Zhao, et al.
Leukemia Research (2024) Vol. 141, pp. 107451-107451
Closed Access | Times Cited: 2
Kai Zhu, Feng-Quan Gou, Ziwen Zhao, et al.
Leukemia Research (2024) Vol. 141, pp. 107451-107451
Closed Access | Times Cited: 2
Hepatitis B Virus–Mediated m6A Demethylation Increases Hepatocellular Carcinoma Stemness and Immune Escape
Yuting Meng, Zheyue Shu, Xueyao Wang, et al.
Molecular Cancer Research (2024) Vol. 22, Iss. 7, pp. 642-655
Open Access | Times Cited: 2
Yuting Meng, Zheyue Shu, Xueyao Wang, et al.
Molecular Cancer Research (2024) Vol. 22, Iss. 7, pp. 642-655
Open Access | Times Cited: 2
RNA Modifications in Pathogenic Viruses: Existence, Mechanism, and Impacts
Yongjin Zou, Zijun Guo, Xing‐Yi Ge, et al.
Microorganisms (2024) Vol. 12, Iss. 11, pp. 2373-2373
Open Access | Times Cited: 2
Yongjin Zou, Zijun Guo, Xing‐Yi Ge, et al.
Microorganisms (2024) Vol. 12, Iss. 11, pp. 2373-2373
Open Access | Times Cited: 2
The bioinformatics and experimental analysis of AlkB family for prognosis and immune cell infiltration in hepatocellular carcinoma
Bi Peng, Yuanliang Yan, Zhijie Xu
PeerJ (2021) Vol. 9, pp. e12123-e12123
Open Access | Times Cited: 15
Bi Peng, Yuanliang Yan, Zhijie Xu
PeerJ (2021) Vol. 9, pp. e12123-e12123
Open Access | Times Cited: 15
Interplay between m6A epitranscriptome and epigenome in cancer: current knowledge and therapeutic perspectives
Guglielmo Bove, Sajid Amin, Mehrad Babaei, et al.
International Journal of Cancer (2022) Vol. 153, Iss. 3, pp. 464-475
Open Access | Times Cited: 11
Guglielmo Bove, Sajid Amin, Mehrad Babaei, et al.
International Journal of Cancer (2022) Vol. 153, Iss. 3, pp. 464-475
Open Access | Times Cited: 11
Role of m6A RNA methylation in the development of hepatitis B virus‐associated hepatocellular carcinoma
Cheng Zhang, Dongjun Dai, Wangjian Zhang, et al.
Journal of Gastroenterology and Hepatology (2022) Vol. 37, Iss. 11, pp. 2039-2050
Open Access | Times Cited: 10
Cheng Zhang, Dongjun Dai, Wangjian Zhang, et al.
Journal of Gastroenterology and Hepatology (2022) Vol. 37, Iss. 11, pp. 2039-2050
Open Access | Times Cited: 10
Role of RNA modifications in carcinogenesis and carcinogen damage response
Michelle Verghese, Emma Wilkinson, Yu‐Ying He
Molecular Carcinogenesis (2022) Vol. 62, Iss. 1, pp. 24-37
Open Access | Times Cited: 7
Michelle Verghese, Emma Wilkinson, Yu‐Ying He
Molecular Carcinogenesis (2022) Vol. 62, Iss. 1, pp. 24-37
Open Access | Times Cited: 7
The role of RNA modifications in hepatocellular carcinoma: functional mechanism and potential applications
Jin‐Xiu Liu, Xiaoping Zhang, Wenhua Xu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Jin‐Xiu Liu, Xiaoping Zhang, Wenhua Xu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
AC099850.3 promotes HBV-HCC cell proliferation and invasion through regulating CD276: a novel strategy for sorafenib and immune checkpoint combination therapy
Aoxiao He, Zhihao Huang, Qian Feng, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Aoxiao He, Zhihao Huang, Qian Feng, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Epigenetic modification of hepatitis B virus infection and related hepatocellular carcinoma
Yaqin Zhang, Weihua Cao, Shiyu Wang, et al.
Virulence (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Yaqin Zhang, Weihua Cao, Shiyu Wang, et al.
Virulence (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Targeting the ALKBH5-NLRP3 positive feedback loop alleviates cardiomyocyte pyroptosis after myocardial infarction
Liu-Gen Cui, Miao-Miao Zhai, Jianjian Yin, et al.
European Journal of Pharmacology (2024), pp. 177247-177247
Closed Access | Times Cited: 1
Liu-Gen Cui, Miao-Miao Zhai, Jianjian Yin, et al.
European Journal of Pharmacology (2024), pp. 177247-177247
Closed Access | Times Cited: 1
Hepatitis B virus X mediates podocyte pyroptosis by regulating the ROS/NLRP3 signaling pathway in hepatitis B virus-associated glomerulonephritis.
Yani Yu, Hui Dong, Jingyi Sun, et al.
PubMed (2022) Vol. 25, Iss. 1, pp. 103-109
Closed Access | Times Cited: 6
Yani Yu, Hui Dong, Jingyi Sun, et al.
PubMed (2022) Vol. 25, Iss. 1, pp. 103-109
Closed Access | Times Cited: 6
Identification of N6-methylandenosine related LncRNAs biomarkers associated with the overall survival of osteosarcoma
Pei Zhang, Keteng Xu, Jingcheng Wang, et al.
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 6
Pei Zhang, Keteng Xu, Jingcheng Wang, et al.
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 6
Multilevel regulation of N6-methyladenosine RNA modifications: Implications in tumorigenesis and therapeutic opportunities
Lili Feng, Rongrong Du, Baitong Chang, et al.
Genes & Diseases (2022) Vol. 10, Iss. 5, pp. 1969-1981
Open Access | Times Cited: 4
Lili Feng, Rongrong Du, Baitong Chang, et al.
Genes & Diseases (2022) Vol. 10, Iss. 5, pp. 1969-1981
Open Access | Times Cited: 4
HBx Modulates Drug Resistance of Sorafenib-Resistant Hepatocellular Carcinoma Cells
Yaping Liu, Xu Liu, Miaosha Luo, et al.
Discovery Medicine (2023) Vol. 35, Iss. 179, pp. 1035-1035
Open Access | Times Cited: 1
Yaping Liu, Xu Liu, Miaosha Luo, et al.
Discovery Medicine (2023) Vol. 35, Iss. 179, pp. 1035-1035
Open Access | Times Cited: 1
ALKBH5-mediated m 6 A modification of CDC6 mRNA impairs gastric cancer tumorigenesis and has prognostic significance
Rui Liang, Xiaoyu Chen, Yi Yu, et al.
Research Square (Research Square) (2023)
Open Access
Rui Liang, Xiaoyu Chen, Yi Yu, et al.
Research Square (Research Square) (2023)
Open Access
N6-methyladenosine methylation of viral genes
Jiting Sun, Yan Zhang, Bing Luo
Future Virology (2023) Vol. 18, Iss. 12, pp. 809-821
Closed Access
Jiting Sun, Yan Zhang, Bing Luo
Future Virology (2023) Vol. 18, Iss. 12, pp. 809-821
Closed Access
The N6-methyladenosine demethylase ALKBH5 regulates the hypoxic HBV transcriptome
Senko Tsukuda, James Michael Harris, Andrea Magrì, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Senko Tsukuda, James Michael Harris, Andrea Magrì, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access